116 results
8-K
EX-99.1
FATE
Fate Therapeutics Inc
5 Mar 19
Fate Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress
4:01pm
persistence and promotes long-term survival in a B-cell leukemia xenograft model. Moreover, as proof-of-concept for dual antigen-specific targeting …
Long-term assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses
CIRM award liability
8-K/A
EX-99.1
FATE
Fate Therapeutics Inc
7 Aug 19
Fate Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Operational Progress
4:01pm
expenses and other current assets
Total current assets
Operating lease right-of-use asset
Other long-term assets
Total assets
Liabilities and stockholders … lease liability, current portion
Long-term debt, current portion
Total current liabilities
Deferred revenue, net of current portion
CIRM award
8-K
EX-99.1
FATE
Fate Therapeutics Inc
2 Mar 20
Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook
4:01pm
receivable
Prepaid expenses and other current assets
Total current assets
Long-term investments
Operating lease right-of-use asset
Other long-term assets … award liability, current portion
Operating lease liability, current portion
Long-term debt, current portion
Total current liabilities
Deferred revenue
8-K
EX-99.1
q810sadw
6 Aug 18
Fate Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Operational Progress
4:10pm
8-K
EX-99.1
0iuw8c5 9j
10 May 18
Fate Therapeutics Reports First Quarter 2018 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-99.1
8fksekvh8vc7e6 q55
5 Nov 19
Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-99.1
8ds djh0ly
6 Aug 19
Fate Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-99.1
w0a o140jaixjej
1 Nov 18
Fate Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-99.1
tyshy5 6m1
3 May 23
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
4:06pm
8-K
EX-99.1
7hagko3q
7 May 19
Fate Therapeutics Reports First Quarter 2019 Financial Results and Highlights Operational Progress
4:15pm